Deep Vein Thrombosis/Pulmonary Embolism: Prophylaxis, Diagnosis, and Management

Thoracic Surgery Clinics

Volumn 22, Issue 1, 2012, Pages 25-28

  Brunelli, Alessandro ^a  

^a OSPEDALI RIUNITI   (Italy)

Author keywords

Deep venous thrombosis; Diagnosis; Prophylaxis; Pulmonary embolism; Therapy; Venous thromboembolism

Indexed keywords

ANTIANEMIC AGENT; ANTICOAGULANT AGENT; D DIMER; ESTROGEN; FONDAPARINUX; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; ORAL CONTRACEPTIVE AGENT; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

AGE; BLEEDING; BLEEDING DISORDER; BLOOD CLOT LYSIS; CANCER SURGERY; CANCER THERAPY; CARDIOGENIC SHOCK; CENTRAL VENOUS CATHETERIZATION; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DEEP VEIN THROMBOSIS; DEHYDRATION; EMBOLECTOMY; ENTERITIS; EPIDURAL ANESTHESIA; FIBRINOLYTIC THERAPY; HEART FAILURE; HEART MUSCLE INJURY; HEART RIGHT VENTRICLE FAILURE; HIGH RISK PATIENT; HORMONE SUBSTITUTION; HUMAN; HYPOTENSION; IMMOBILIZATION; INTENSIVE CARE; LEG INJURY; LEG VARICOSIS; LENGTH OF STAY; LOW DRUG DOSE; LUNG EMBOLISM; LUNG RESECTION; MYELOPROLIFERATIVE DISORDER; NEOPLASM; NEPHROTIC SYNDROME; OBESITY; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PERCUTANEOUS THROMBECTOMY; PHLEBITIS; PREGNANCY; PRIORITY JOURNAL; PUERPERIUM; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY FAILURE; REVIEW; RISK FACTOR; SPINAL ANESTHESIA; SURGICAL TECHNIQUE; THORAX SURGERY; THROMBOPHILIA; TREATMENT PLANNING;

ANGIOGRAPHY; DISEASE MANAGEMENT; HUMANS; MORBIDITY; PULMONARY EMBOLISM; RISK ASSESSMENT; THORACIC SURGICAL PROCEDURES; THROMBOLYTIC THERAPY; TOMOGRAPHY, X-RAY COMPUTED; UNITED STATES; VENOUS THROMBOSIS;

EID: 81855185390     PISSN: 15474127     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thorsurg.2011.08.014     Document Type: Review

References (18)

1. Goldhaber S.Z. Pulmonary embolism. Lancet 2004, 363:1295-1305.
2. Goldhaber S.Z., Visani L., De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999, 353:1386-1389.
3. Geerts W.H., Heit J.A., Clagett P.G., et al. Prevention of venous thromboembolism. Chest 2001, 119(Suppl 1):132S-175S.
4. Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital 2010, National Institute for Health and Clinical Excellence, (NICE clinical guideline No. 92.) Available at:, Accessed June 30, 2011. http://guidance.nice.org.uk/CG92.
5. Geerts W.H., Bergqvist D., Pineo G.F., et al. American College of Chest Physicians. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest 2008, 133:381S-453S.
6. Anderson F.A., Spencer F.A. Risk factors for venous thromboembolism. Circulation 2003, 107:I9-I16.
7. Lausen I., Jensen R., Jorgensen L.N., et al. Incidence and prevention of deep venous thrombosis occurring late after general surgery: randomised controlled study of prolonged thromboprophylaxis. Eur J Surg 1998, 164:657-663.
8. Bergqvist D., Agnelli G., Cohen A.T., et al. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med 2002, 346:975-980.
9. Rasmussen M.S. Preventing thromboembolic complications in cancer patients after surgery: a role for prolonged thromboprophylaxis. Cancer Treat Rev 2002, 28:141-144.
10. Treasure T., Chong L.Y., Sharpin C.E. Perioperative prophylaxis against venous thromboembolism in major lung resection. Difficult decision in thoracic surgery. An evidence based approach 2011, 165-169. Springer-Verlag London Limited, London. M. Ferguson (Ed.).
11. Torbicki A., Perrier A., Konstantinides S., et al. ESC Committee for Practice Guidelines (CPG). Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J 2008, 29:2276-2315.
12. Jaff M.R., McMurtry M.S., Archer S.L., et al. American Heart Association Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation; American Heart Association Council on Peripheral Vascular Disease; American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation 2011, 123:1788-1830.
13. Goldhaber S.Z., Haire W.D., Feldstein M.L., et al. Alteplase versus heparin in acute pulmonary embolism: randomized trial assessing right-ventricular function and pulmonary perfusion. Lancet 1993, 341:507-511.
14. Dalla-Volta S., Palla A., Santolicandro A., et al. PAIMS 2: alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen Activator Italian Multicenter Study 2. J Am Coll Cardiol 1992, 20:520-526.
15. Levine M., Hirsh J., Weitz J., et al. A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism. Chest 1990, 98:1473-1479.
16. Marini C., Di Ricco G., Rossi G., et al. Fibrinolytic effects of urokinase and heparin in acute pulmonary embolism: a randomized clinical trial. Respiration 1988, 54:162-173.
17. Ly B., Arnesen H., Eie H., et al. A controlled clinical trial of streptokinase and heparin in the treatment of major pulmonary embolism. Acta Med Scand 1978, 203:465-470.
18. Tibbutt D.A., Chesterman C.N. Pulmonary embolism: current therapeutic concepts. Drugs 1976, 11:161-192.